triazolam has been researched along with Facial Pain in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Facial Pain: Pain in the facial region including orofacial pain and craniofacial pain. Associated conditions include local inflammatory and neoplastic disorders and neuralgic syndromes involving the trigeminal, facial, and glossopharyngeal nerves. Conditions which feature recurrent or persistent facial pain as the primary manifestation of disease are referred to as FACIAL PAIN SYNDROMES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with chronic orofacial pain often report disturbances in sleep, leading to the hypothesis that nocturnal motor hyperactivity of the muscles of mastication may contribute to the nociceptive process." | 2.69 | Triazolam improves sleep but fails to alter pain in TMD patients. ( DeNucci, DJ; Dionne, RA; Sobiski, C, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeNucci, DJ | 1 |
| Sobiski, C | 1 |
| Dionne, RA | 1 |
1 trial available for triazolam and Facial Pain
| Article | Year |
|---|---|
Triazolam improves sleep but fails to alter pain in TMD patients.
Topics: Adult; Chronic Disease; Cross-Over Studies; Double-Blind Method; Electromyography; Facial Pain; GABA | 1998 |